Chambers Michael Andrew's Form 4 filing
Sarepta Therapeutics, Inc. (SRPT) · filed Aug 15, 2023
- Accession no.
- 0001209191-23-045766
- Filed
- Aug 15, 2023
- Trade date
- Aug 14, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.09M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chambers Michael AndrewCIK 0001932527 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | Common Stock | PPurchaseAcquired | +5,947 | $109.19 | +$649,352.93 | 242,964 | Indirect | |
| Aug 14, 2023 | Common Stock | PPurchaseAcquired | +4,032 | $109.89 | +$443,076.48 | 246,996 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.